aimovig

Aimovig was the first migraine preventative therapy to launch in market. This launch campaign, “enough already”, won “Best Launch Campaign” at the MM&M awards in 2019. “enough already” visually represents the thought that “if physicians were able to see a migraine, would they do something about it?”.